Unlike "Dull's" drivel or the frightful beats of BongoBozo, NeuVax has earned it's rightful place as the most promising and revolutionary Oncology potential of the Decade. Today's NeuVax is unmistakably and undeniably a highly evolved product based not only upon the highly successful 60-month Phase 2 Trials, but based even further upon the research and expertise of countless dedicated scientists and clinicians over the course of the past ten years. Dull56 and BongoBozo are but insignificant parasitic mites eagerly lounging upon the sometimes tumultuous GALE roller-ride. Neither CYTR, nor Kriegs, nor Apthera, nor BongoBrain, nor a very Dull56 can alter the inevitable intersection of Phase 3 NeuVax Clinicals with the FDA Stamp of Approval. The past - it's gone and in some respects way far behind. The NeuVax Future is the revolution I envision and the one which evokes Hope and Promise for millions.